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We present the longest reported case of breast cancer recurrence, 52 years after initial diagnosis, in a patient initially treated
with Halsted mastectomy. Observation and palpation of the chest wall resulted in late presentation, and this patient went on
to demonstrate metastatic disease. Current surveillance guidelines lack speciﬁc recommendations regarding monitoring of the
ipsilateral chest wall. In addition, the growing utilization of breast reconstruction poses an additional challenge to surveillance
strategiesoftheipsilateralbreast.However,theemergenceofMRImaypresentanewopportunitytoidentifyipsilateralrecurrence.
The changing landscape of breast cancer therapy warrants guidance from groups of national import such as ASCO, in the
surveillance of breast cancer patients.
1.Introduction
Breast cancer recurrence surveillance in mastectomy patients
remains an open issue in the literature. Local recurrence
rates in patients treated with mastectomy are reported to be
from 2.3 to as high as 30 percent [1–9]. While the American
Society of Clinical Oncology (ASCO) recommends regular
mammograms for all women previously treated with breast-
conserving therapy [10, 11], these guidelines are not speciﬁc
to surveillance of the ipsilateral chest wall in the mastectomy
patient. Chest wall recurrence in these patients may only
be detected via observation or palpation, and the chest wall
cannot be adequately imaged using current mammography
techniques.
The wide variety of available techniques for breast cancer
therapy has given physicians greater ﬂexibility to treat breast
cancer, both oncologically and aesthetically with breast
reconstruction.However,thishasalsopresentedgreaterchal-
lenges to physicians to develop treatment-speciﬁc protocols
for recurrence surveillance.
The following case highlights a local/regional recurrence
52 years after initial Halsted mastectomy. This is the longest
reported case of local recurrence in the indexed literature to
our knowledge—two other publications report recurrences
after 48 and 32 years [12, 13]. Additionally, this case raises
several key points which deserve attention in the further
development of postmastectomy surveillance recommenda-
tions.
2. Methods
2.1. Case. An 80-year-old woman with a previous history
of breast cancer presented with an erythematous, indurated
lesion on the right chest wall. She had previously undergone
a radical mastectomy on the right breast 52 years earlier for
breast carcinoma; additionally she was treated with radiation
therapy at that time. The patient had undergone only place-
ment of a split-thickness skin graft placed directly over her
ribs as reconstruction after her initial resection. The patient
has undergone routine mammographic examination of her2 Case Reports in Oncological Medicine
Figure 1: An 80-year-old woman with local chest wall recurrence
of breast cancer 52 years after Halsted mastectomy.
contralateral breast, but no further imaging was performed
on her ipsilateral mastectomy site since the time of her
initial treatment. The patient presented to a dermatologist
in August of 2007 after development of a 3cm × 3cmred,
scaly lesion on the right chest wall at the medial aspect of the
skin graft (Figure 1). The patient noted that this lesion had
become painful and friable with intermittent bleeding.
A shave biopsy of the skin graft was performed which
revealedaninvasive,moderatelydiﬀerentiatedsquamouscell
carcinoma. Wide local excision of the erythematous lesion,
including the underlying rib, was then performed. This
specimen revealed a poorly diﬀerentiated adenocarcinoma
consistent with locally recurrent breast cancer. The deep
margin was positive, and the tumor was found by stains to
be ER+/PR+ and Her2/neu+. A CT scan further revealed the
presence of pulmonary metastases. The patient underwent
local tissue rearrangement using the contralateral breast skin
to close the defect, followed by chemotherapy for treatment
of her pulmonary metastases (Figure 2).
3. Discussion
In the case presented here, local recurrence occurred 52 years
after mastectomy for breast cancer treatment. The risk of
locoregional recurrence in breast cancer patients following
mastectomy has been reported to be between 2.3 and 30
percent [1–9]. Some studies report that up to 80 percent of
patients treated with newer skin-sparing mastectomy tech-
niques have some remaining breast tissue [14, 15]. However,
no standard practice exists for surveillance of the ipsilateral
chest wall.
Based on data from the Breast Cancer Treatment Ef-
fectiveness in Older Women (BOW) study, Field et al. have
shown that, by the fourth year after treatment, only 60% of
breast cancer survivors aged 65 and over visit an oncologist
or breast surgeon [16]. Less than 70% of women receive a
surveillance mammogram during their fourth year of fol-
lowup after breast cancer treatment [16]. Nearly a one-third
reduction in breast cancer mortality rate has been shown to
beassociatedwitheachadditional surveillancemammogram
for breast cancer survivors over 65 years [17]. Data from
the Surveillance, Epidemiology, and End Results (SEER)
Figure 2: The same patient after chest wall lesion excision and local
tissue rearrangement using the skin from her contralateral breast.
database demonstrate a decreased risk of breast-cancer-spe-
cific mortality in women who receive a mammogram within
a one- or two-year interval before death [18]. It should be
noted that these studies address the use of surveillance mam-
mography and are not speciﬁc to ipsilateral surveillance. In
mastectomy patients, the lack of available tissue obviates the
use of mammography for ipsilateral surveillance. In the case
reported here, observation and palpation were inadequate
for recurrence detection. By the time the lesion was evident
on clinical exam, the underlying ribs were involved and
pulmonary metastasis had occurred. This raises an impor-
tant question regarding the appropriate method of ipsilateral
chestwallsurveillance.Whileobservationandpalpationmay
eventually detect recurrence, it may not be suﬃcient for
timely detection.
Given the increased rates of postmastectomy breast re-
construction, we must also consider surveillance of the re-
constructed breast cancer survivor. The literature shows that
between 8 and 16 percent of breast cancer patients treated
with mastectomy undergo postmastectomy reconstruction,
and this number continues to increase [19–24]. Currently,
therearenospeciﬁcguidelinesforpostreconstructivesurveil-
lance of the ipsilateral breast [5, 10, 11]. A recent systematic
review concluded that there is currently little evidence stud-
ying surveillance in the reconstructed breast and that further
research is needed [25]. Furthermore, reconstruction itself
can be performed using a variety of techniques. Implant-
based reconstruction can be performed using saline or sili-
coneimplantswhichinadditionmaybeplacedeitherdeepor
superﬁcial to the pectoralis muscle. Autologous ﬂap recon-
structionshouldbeperformedusingavarietyofthepatient’s
own tissues including abdomen (transverse abdominus
rectus myocutaneous ﬂap), buttocks (gluteal myocutaneous
ﬂap),andeventhigh(gracilisﬂap).Thesevariablesconfound
the reliability of the manual exam and mammogram.
Finally, magnetic resonance imaging (MRI) oﬀers a new-
er modality for breast cancer screening in certain indicated
patient subgroups; however, current guidelines from ASCO
recommend against the use of MRI for general breast cancer
surveillance [10]. The utility of MRI for surveillance in the
reconstructed breast still remains unaddressed by current
ASCO guidelines.Case Reports in Oncological Medicine 3
4. Conclusion
Surveillance for local breast cancer recurrence remains a
debated topic in the scientiﬁc literature. We report a case
of local recurrence in an 80-year-old woman, 52 years after
initial treatment with Halsted mastectomy; observation and
palpation of the chest wall resulted in late presentation,
and this patient went on to demonstrate metastatic disease.
Current surveillance guidelines lack speciﬁc recommenda-
tions regarding monitoring of the ipsilateral chest wall. In
addition, the growing utilization of breast reconstruction
poses an additional challenge to surveillance strategies of
the ipsilateral breast. However, the emergence of MRI may
present a new opportunity to identify ipsilateral recurrence.
The changing landscape of breast cancer therapy warrants
guidance from groups of national import such as ASCO, in
the surveillance of breast cancer patients.
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